Paragon acquired by NJ-based Catalent for $1.2 billion

Pete Buzy, president and CEO of Paragon Bioservices, and Gov. Larry Hogan at the grand opening of the firm's new manufacturing facility in Anne Arundel County. (Submitted photo)

Baltimore biotech firm Paragon Bioservices has been acquired by the New Jersey-based drug manufacturer Catalent, Inc. for $1.2 billion, Paragon announced Monday. Paragon, which specializes in biologics contract development and manufacturing, especially in gene therapy using viral vector manufacturing, employs ...

Read More »